Xilio Therapeutics, Inc. (XLO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 43.56M |
| Enterprise value | 11.36M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 1.18 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | -0.09 |
| 52-week change 3 | -61.56% |
| S&P500 52-week change 3 | 26.27% |
| 52-week high 3 | 3.2500 |
| 52-week low 3 | 0.4900 |
| 50-day moving average 3 | 1.0219 |
| 200-day moving average 3 | 1.4460 |
Share statistics
| Avg vol (3-month) 3 | 1.24M |
| Avg vol (10-day) 3 | 215.05k |
| Shares outstanding 5 | 36.91M |
| Implied shares outstanding 6 | 36.91M |
| Float 8 | 20.2M |
| % held by insiders 1 | 25.79% |
| % held by institutions 1 | 41.98% |
| Shares short (30 Apr 2024) 4 | 456.51k |
| Short ratio (30 Apr 2024) 4 | 0.29 |
| Short % of float (30 Apr 2024) 4 | 1.55% |
| Short % of shares outstanding (30 Apr 2024) 4 | 1.24% |
| Shares short (prior month 28 Mar 2024) 4 | 54.24k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -49.44% |
| Return on equity (ttm) | -107.25% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -77.23M |
| Net income avi to common (ttm) | -76.4M |
| Diluted EPS (ttm) | -2.7800 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 44.7M |
| Total cash per share (mrq) | 1.3 |
| Total debt (mrq) | 12.55M |
| Total debt/equity (mrq) | 34.08% |
| Current ratio (mrq) | 3.02 |
| Book value per share (mrq) | 1.33 |
Cash flow statement
| Operating cash flow (ttm) | -68.62M |
| Levered free cash flow (ttm) | -42.32M |
© 2024 Yahoo. All rights reserved.